Estimation of General Practitioner Visits, Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus and Influenza Virus, and Costs Associated With Hospitalizations, in Older Adults in France From 2010 to 2020 - Summary - MDSpire
Advertisement
Estimation of General Practitioner Visits, Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus and Influenza Virus, and Costs Associated With Hospitalizations, in Older Adults in France From 2010 to 2020
To estimate the incidence of GP visits, hospitalizations, and deaths attributable to both RSV and influenza in French adults aged ≥50 years, with a specific focus on those aged ≥65 years, and to calculate hospitalization-related costs.
Key Findings:
RSV infection was responsible for an estimated 647,619 GP visits, 24,319 hospitalizations, and 878 deaths annually among adults aged ≥65 years.
Incidence rates for GP visits for RSV were twice that of influenza, while hospitalization rates were similar and mortality was lower for RSV.
Mean annual cost of RSV-attributable hospitalizations was approximately 105 million €, comparable to influenza.
Interpretation:
The burden of RSV disease in older adults in France is higher than previously reported, indicating a need for increased awareness and potential vaccination campaigns to mitigate this public health issue.
Limitations:
Underestimation of RSV burden due to diagnostic challenges and infrequent testing, which may skew the perceived impact of RSV.
Reliance on administrative data may not capture all cases accurately, potentially leading to an incomplete understanding of the disease burden.
Conclusion:
This study underscores the significant impact of RSV in older adults, suggesting that model-based approaches can aid in evaluating the effects of RSV vaccination strategies, aligning with existing literature on the need for improved diagnostic practices.
